Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Dayvigo for insomnia

Dec. 23, 2019

New protein cereblon ligands identified at C4 Therapeutics

Dec. 23, 2019

Merck & Co. patents HIV integrase inhibitors

Dec. 23, 2019

Shionogi presents new histone deacetylase inhibitors

Dec. 23, 2019

New cannabinoid CB1/2 receptor ligands discovered at AL&AM Pharmachem

Dec. 23, 2019

Jiangsu Vcare Pharmatech describes new EGFR inhibitors

Dec. 23, 2019

'Aggrephagy' is viral immune evasion mechanism

Dec. 23, 2019

Ryaltris receives marketing approval in Australia

Dec. 23, 2019

Microbiome-based therapies may be useful against ALDs

Dec. 23, 2019

Freeline Therapeutics describes novel next-generation AAV-hFVIII vector candidate

Dec. 23, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...